GLUEMonte Rosa Therapeutics, Inc.

HealthcareUSD
$14.37

Is it growing?

Is GLUE growing?

Years of annual history on file
6

Years of annual history on file · FY2020 to FY2025, as filed

Details›
Revenue FY2023
$0
Revenue FY2024
$76M
Revenue FY2025
$124M

Annual income statements as filed with the SEC.

Biotechnology

Ranks #111 of 145 by Smart Score

Compare peers
TYRA+1.9%
Tyra Biosciences, Inc.
RAPP-2.7%
Rapport Therapeutics, Inc.
MESO-6.8%
Mesoblast Limited
TSHA-11%
Taysha Gene Therapies, Inc.
IOVA-0.94%
Iovance Biotherapeutics, Inc.
RXRX+3.4%
Recursion Pharmaceuticals, Inc.